WO2026115579 - NOVEL CO-CRYSTAL OF SAROGLITAZAR WITH POLY(D-GLUCOSAMINE)
National phase entry is expected:
Publication Number
WO/2026/115579
Publication Date
04.06.2026
International Application No.
PCT/IN2025/051955
International Filing Date
28.11.2025
Title **
[English]
NOVEL CO-CRYSTAL OF SAROGLITAZAR WITH POLY(D-GLUCOSAMINE)
[French]
NOUVEAU CO-CRISTAL DE SAROGLITAZAR AVEC LA POLY(D-GLUCOSAMINE)
Applicants **
ZYDUS LIFESCIENCES LIMITED
Inventors
IYER, Pravin
PINGALI, Harikishore
ZAWARE, Pandurang
BANERJEE, Kaushik
Priority Data
202421093566
29.11.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| * | |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2044 | |
| EPO | Filing, Examination, Granting | 11804 | |
| Japan | Filing, Examination, Granting | 2045 | |
| South Korea | Filing, Examination, Granting | 1854 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
23,087
Contact Us
Abstract[English]
The present invention relates to novel Poly(D-glucosamine) co-crystals of Saroglitazar. Specifically, the present invention provides co-crystal of Saroglitazar of formula (I) and Chitosan, process for the preparation of said co-crystal, use thereof and pharmaceutical compositions comprising the same.[French]
La présente invention concerne de nouveaux co-cristaux de Poly(D-glucosamine) de Saroglitazar. Plus précisément, la présente invention fournit un co-cristal de Saroglitazar de formule (I) et de Chitosane, un procédé pour la préparation dudit co-cristal, son utilisation et des compositions pharmaceutiques le comprenant.